Free cookie consent management tool by TermsFeed

iQure Pharma iQ-007 Receives Orphan Drug Status

Jan 23, 2025News

iQure Pharmaceuticals

01/23/2025 – iQure Pharma’s iQ-007 Receives FDA Orphan Drug Designation for Dravet’s Syndrome.

Learn the Full Story here!

Latest News